# FDA Inspection 1023216 - Biomat USA, Inc. - August 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8855fb60-ad67-4c99-8df0-39381773a5d3
Source feed: FDA_Inspections

> FDA Inspection 1023216 for Biomat USA, Inc. on August 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1023216
- Company Name: Biomat USA, Inc.
- Inspection Date: 2017-08-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 820154 - 2013-02-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cf74a144-bcc0-4fc9-bfaa-51f2aee60463)
- [FDA Inspection 726568 - 2011-05-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/11440abf-3d86-4884-83f5-eb38a4d21ea5)

Company: https://www.keypedia.com/companies/biomat-usa-inc/f14a8f60-c3fa-408a-a436-b9939f07a3f1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d